Physiologic, biochemical, and pathological backgrounds of levodopa and possibilities for the future.
D000818:Animals; D001921:Brain / Q000378:metabolism*; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D004298:Dopamine / Q000378:metabolism*; D006801:Humans; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D051379:Mice; D010300:Parkinson Disease / Q000188:drug therapy*; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D010648:Phenylacetates / Q000378:metabolism; D012110:Reserpine
D010648:Phenylacetates; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D004298:Dopamine